Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses
2019-01-01 Pantavou, K; Yiallourou, Ai; Piovani, D; Evripidou, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S; Nikolopoulos, Gk
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease
2019-01-01 Kotze, Pg; Spinelli, A; Warusavitarne, J; Di Candido, F; Sahnan, K; Adegbola, So; Danese, S
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease A Randomized Clinical Trial
2015-01-01 Hawkey, Cj; Allez, M; Clark, Mm; Labopin, M; Lindsay, Jo; Ricart, E; Rogler, G; Rovira, M; Satsangi, J; Danese, S; Russell, N; Gribben, J; Johnson, P; Larghero, J; Thieblemont, C; Ardizzone, S; Dierickx, D; Ibatici, A; Littlewood, T; Onida, F; Schanz, U; Vermeire, S; Colombel, Jf; Jouet, Jp; Clark, E; Saccardi, R; Tyndall, A; Travis, S; Farge, D
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner?
2010-01-01 Fiorino, G.; Rovida, S.; Correale, C.; Malesci, A.; Danese, S.
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease
2020-01-01 Pellino, G.; Keller, D. S.; Sampietro, G. M.; Angriman, I.; Carvello, M.; Celentano, V.; Colombo, F.; Di Candido, F.; Laureti, S.; Luglio, G.; Poggioli, G.; Rottoli, M.; Scaringi, S.; Sciaudone, G.; Sica, G.; Sofo, L.; Leone, S.; Danese, S.; Spinelli, A.; Delaini, G.; Selvaggi, F.
Development and validation of the Nancy histological index for UC
2017-01-01 Marchal-Bressenot, A; Salleron, J; Boulagnon-Rombi, C; Bastien, C; Cahn, V; Cadiot, G; Diebold, Md; Danese, S; Reinisch, W; Schreiber, S; Travis, S; Peyrin-Biroulet, L
Thrombotic complications in inflammatory bowel disease: A multifactorial etiology
2001-01-01 Papa, A; De Stefano, V; Danese, S; Gasbarrini, A; Gasbarrini, G
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013-01-01 Peyrin-Biroulet, L; Fiorino, G; Buisson, A; Danese, S
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)
2015-01-01 van Assche, G; Dignass, A; Bokemeyer, B; Danese, S; Gionchetti, P; Moser, G; Beaugerie, L; Gomolion, F; Hauser, W; Herrlinger, K; Oldenburg, B; Panes, J; Portela, F; Rogier, G; Stein, J; Tilg, H; Travis, S; Lindsay, Jo
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic
2020-01-01 D’Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?
2020-01-01 D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study
2012-01-01 Sorrentino, D; Terrosu, G; Paviotti, A; Geraci, M; Avellini, C; Zoli, G; Fries, W; Danese, S; Occhipinti, P; Croatto, T; Zarifi, D
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
2016-01-01 Peyrin-Biroulet, L; Panes, J; Sandborn, Wj; Vermeire, S; Danese, S; Feagan, Bg; Colombel, Jf; Hanauer, Sb; Rycroft, B
Anti TNF-alpha Treatment For Crohn's Disease: "Menage A Trois"
2010-01-01 Danese, S
Biological agents for ulcerative colitis : Hypes and hopes
2008-01-01 Danese, S.; Angelucci, E.; Malesci, A.; Caprilli, R.
The Crohn's Disease-Ulcerative Colitis Clinical Appraisal
2016-01-01 D'Haens, G; Bressler, B; Danese, S; Gibson, P; Hanauer, Sb; Sandborn, W
Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
2019-01-01 Argollo, Mc; Allocca, M; Furfaro, F; Peyrin-Biroulet, L; Danese, S
Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review
2010-01-01 Oussalah, A; Danese, S; Peyrin-Biroulet, L
Medical Challanges in Inflammatory Bowel Disease: Quo Vadis in Disease Complexity?
2014-01-01 Danese, S; Peyrin-Biroulet, L
Diffusion-weighted MRI in inflammatory bowel disease
2018-01-01 Pouillon, L; Laurent, V; Pouillon, M; Bossuyt, P; Bonifacio, C; Danese, S; Deepak, P; Loftus, Ev; Bruining, Dh; Peyrin-Biroulet, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses | 1-gen-2019 | Pantavou, K; Yiallourou, Ai; Piovani, D; Evripidou, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S; Nikolopoulos, Gk | |
| Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease | 1-gen-2019 | Kotze, Pg; Spinelli, A; Warusavitarne, J; Di Candido, F; Sahnan, K; Adegbola, So; Danese, S | |
| Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease A Randomized Clinical Trial | 1-gen-2015 | Hawkey, Cj; Allez, M; Clark, Mm; Labopin, M; Lindsay, Jo; Ricart, E; Rogler, G; Rovira, M; Satsangi, J; Danese, S; Russell, N; Gribben, J; Johnson, P; Larghero, J; Thieblemont, C; Ardizzone, S; Dierickx, D; Ibatici, A; Littlewood, T; Onida, F; Schanz, U; Vermeire, S; Colombel, Jf; Jouet, Jp; Clark, E; Saccardi, R; Tyndall, A; Travis, S; Farge, D | |
| Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? | 1-gen-2010 | Fiorino, G.; Rovida, S.; Correale, C.; Malesci, A.; Danese, S. | |
| Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease | 1-gen-2020 | Pellino, G.; Keller, D. S.; Sampietro, G. M.; Angriman, I.; Carvello, M.; Celentano, V.; Colombo, F.; Di Candido, F.; Laureti, S.; Luglio, G.; Poggioli, G.; Rottoli, M.; Scaringi, S.; Sciaudone, G.; Sica, G.; Sofo, L.; Leone, S.; Danese, S.; Spinelli, A.; Delaini, G.; Selvaggi, F. | |
| Development and validation of the Nancy histological index for UC | 1-gen-2017 | Marchal-Bressenot, A; Salleron, J; Boulagnon-Rombi, C; Bastien, C; Cahn, V; Cadiot, G; Diebold, Md; Danese, S; Reinisch, W; Schreiber, S; Travis, S; Peyrin-Biroulet, L | |
| Thrombotic complications in inflammatory bowel disease: A multifactorial etiology | 1-gen-2001 | Papa, A; De Stefano, V; Danese, S; Gasbarrini, A; Gasbarrini, G | |
| First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | 1-gen-2013 | Peyrin-Biroulet, L; Fiorino, G; Buisson, A; Danese, S | |
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version) | 1-gen-2015 | van Assche, G; Dignass, A; Bokemeyer, B; Danese, S; Gionchetti, P; Moser, G; Beaugerie, L; Gomolion, F; Hauser, W; Herrlinger, K; Oldenburg, B; Panes, J; Portela, F; Rogier, G; Stein, J; Tilg, H; Travis, S; Lindsay, Jo | |
| Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic | 1-gen-2020 | D’Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio | |
| Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins? | 1-gen-2020 | D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent | |
| Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study | 1-gen-2012 | Sorrentino, D; Terrosu, G; Paviotti, A; Geraci, M; Avellini, C; Zoli, G; Fries, W; Danese, S; Occhipinti, P; Croatto, T; Zarifi, D | |
| Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions | 1-gen-2016 | Peyrin-Biroulet, L; Panes, J; Sandborn, Wj; Vermeire, S; Danese, S; Feagan, Bg; Colombel, Jf; Hanauer, Sb; Rycroft, B | |
| Anti TNF-alpha Treatment For Crohn's Disease: "Menage A Trois" | 1-gen-2010 | Danese, S | |
| Biological agents for ulcerative colitis : Hypes and hopes | 1-gen-2008 | Danese, S.; Angelucci, E.; Malesci, A.; Caprilli, R. | |
| The Crohn's Disease-Ulcerative Colitis Clinical Appraisal | 1-gen-2016 | D'Haens, G; Bressler, B; Danese, S; Gibson, P; Hanauer, Sb; Sandborn, W | |
| Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease? | 1-gen-2019 | Argollo, Mc; Allocca, M; Furfaro, F; Peyrin-Biroulet, L; Danese, S | |
| Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review | 1-gen-2010 | Oussalah, A; Danese, S; Peyrin-Biroulet, L | |
| Medical Challanges in Inflammatory Bowel Disease: Quo Vadis in Disease Complexity? | 1-gen-2014 | Danese, S; Peyrin-Biroulet, L | |
| Diffusion-weighted MRI in inflammatory bowel disease | 1-gen-2018 | Pouillon, L; Laurent, V; Pouillon, M; Bossuyt, P; Bonifacio, C; Danese, S; Deepak, P; Loftus, Ev; Bruining, Dh; Peyrin-Biroulet, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1